Adult Stem Cell Study Demonstrates Improved Quality Of Life For Patients Suffering From Spinal Cord Injury
DaVinci Biosciences announced the publication of study results demonstrating the safety and feasibility of its acute and chronic spinal cord injury therapy platform in issue 17(12) of Cell Transplantation, a peer-reviewed journal focused on regenerative medicine.
[Read the full article here]Related News:
Stem Cell Administration Study Demonstrates Improved Quality Of Life For Patients Suffering From Spinal Cord Injury
Stem Cell Administration Study Demonstrates Improved Quality of Life …
Spinal Cord Injury Patient Treated With Non-Matched Adult Stem Cells